N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease

NCT04761952 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Crohn Disease
Polyunsaturated Acid Lipidosis

Interventions

DRUG: azathioprine
DRUG: infliximab
DRUG: N-3 Polyunsaturated Fatty Acids

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University